Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.

Inclusion Criteria:

• 6-month history of migraine
• Migraine attacks typically mild when they begin with 1-4 migraine attacks per month

Exclusion Criteria:

• Heart disease
• High blood pressure